Assignee
KOBIOLABS INC
KR·12 granted patents·5 pending applications·3 citations·filing 2016–2025
Top patents by PatentIndex Score
17 records- 0192US11285183B2Lactobacillus gasseri KBL697 strain and use thereofKOBIOLABS INC·Filed 2020·Granted Mar 29, 2022·2 cites·17 claims
- 0282US11291698B2Lactobacillus paracasei strain and use thereofKOBIOLABS INC·Filed 2020·Granted Apr 5, 2022·1 cites·7 claims
- 0373US11633439B2Lactobacillus crispatus KBL693 strain and use thereofKOBIOLABS INC·Filed 2021·Granted Apr 25, 2023·0 cites·14 claims
- 0470US11992511B2Lactobacillus paracasei strain and use thereofKOBIOLABS INC·Filed 2022·Granted May 28, 2024·0 cites·17 claims
- 0570US11819526B2Lactobacillus Gasseri KBL697 strain and use thereofKOBIOLABS INC·Filed 2022·Granted Nov 21, 2023·0 cites·21 claims
- 0668US11903980B2Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial communityKOBIOLABS INC·Filed 2022·Granted Feb 20, 2024·0 cites·8 claims
- 0762US12441979B2Akkermansia muciniphila strain and use thereofKOBIOLABS INC·Filed 2019·Granted Oct 14, 2025·0 cites·3 claims
- 0861US12070477B2Lactobacillus sp. strain having ability to inhibit growth of vaginal pathogenic microorganismsKOBIOLABS INC·Filed 2020·Granted Aug 27, 2024·0 cites·5 claims
- 0961US11510948B2Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial communityKOBIOLABS INC·Filed 2018·Granted Nov 29, 2022·0 cites·11 claims
- 1060US12274718B2Composition and method for preventing, alleviating, or treating liver injuryKOBIOLABS INC·Filed 2020·Granted Apr 15, 2025·0 cites·14 claims
- 1159US2018117100A1Lactobacillus sp. strain having ability to inhibit proliferation of virginal pathogenic microorganismsKOBIOLABS INC·Filed 2016·Application pending·0 cites
- 1259US2025320455A1Akkermansia muciniphila strain and use thereofKOBIOLABS INC·Filed 2025·Application pending·0 cites
- 1349US2023293600A1Faecalibacterium prausnitzii strain and uses there ofKOBIOLABS INC·Filed 2021·Application pending·0 cites
- 1449US2023173019A1Protein Variant Having GLP-1 Inducing Activity and Use ThereofKOBIOLABS INC·Filed 2021·Application pending·0 cites
- 1548US2023046756A1Lactobacillus Acidophilus KBL409 Strain and Use ThereofKOBIOLABS INC·Filed 2020·Application pending·0 cites
- 1647US11602552B2Lactobacillus plantarum KBL396 strain and use thereofKOBIOLABS INC·Filed 2019·Granted Mar 14, 2023·0 cites·6 claims
- 1731US11365452B2Composition for diagnosing or predicting risk of metabolic syndrome or metabolic syndrome-related diseases using human oral microbiomeKOBIOLABS INC·Filed 2017·Granted Jun 21, 2022·0 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →